Catalyst Biosciences, Inc.
(NASDAQ : CBIO)

( )
CBIO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading CBIO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.96%164.701.2%$479.34m
GILDGilead Sciences, Inc.
1.31%67.121.0%$477.88m
BIIBBiogen Inc.
3.62%286.891.2%$430.46m
CELGCelgene Corporation
1.92%125.521.1%$374.36m
REGNRegeneron Pharmaceuticals, Inc.
0.13%372.432.7%$322.82m
VRTXVertex Pharmaceuticals Incorporated
-0.33%117.271.8%$289.46m
INCYIncyte Corporation
0.39%124.392.1%$254.11m
ALXNAlexion Pharmaceuticals, Inc.
0.85%120.551.6%$218.34m
ILMNIllumina, Inc.
0.72%181.503.3%$166.56m
TSROTESARO, Inc.
0.94%138.4415.3%$142.12m
NBIXNeurocrine Biosciences, Inc.
3.55%53.624.5%$102.87m
BMRNBioMarin Pharmaceutical Inc.
0.72%94.194.3%$98.65m
KITEKite Pharma, Inc.
-2.04%80.5715.6%$97.22m
CLVSClovis Oncology, Inc.
1.65%57.8618.2%$93.56m
AAgilent Technologies, Inc.
0.70%54.821.6%$87.06m

Company Profile

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It focuses on creating and developing novel medicines to address serious medical conditions for patients who need new or better treatment options. The company was founded on August 5, 2002 and is headquartered in South San Francisco, CA.